Pure Global

ANTIBODY FOR CELIAC DISEASE - ANVISA Registration 80213250649

Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80213250649 and manufactured by BIOSYSTEMS S/A. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80213250649
Registration Details
ANVISA Registration Number: 80213250649
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

ANTICORPOS ANTI-tTRANSGLUTAMINASE IgG
Risk Class II

Registration Details

80213250649

25351155622201704

64128853000196

Company Information

BIOSYSTEMS S/A
Spain
PT: ESPANHA

Dates and Status

Apr 24, 2017

VIGENTE

09/18/2025 19:00:01